Fortitude Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
1,058
+142
| +16% | +$57.6K | 0.25% | 86 |
|
|
2025
Q1 | $400K | Sell |
916
-2
| -0.2% | -$874 | 0.29% | 72 |
|
|
2024
Q4 | $478K | Buy |
918
+8
| +0.9% | +$4.16K | 0.29% | 69 |
|
|
2024
Q3 | $563K | Sell |
910
-68
| -7% | -$42.1K | 0.36% | 59 |
|
|
2024
Q2 | $541K | Buy |
978
+316
| +48% | +$175K | 0.32% | 60 |
|
|
2024
Q1 | $385K | Sell |
662
-161
| -20% | -$93.6K | 0.22% | 103 |
|
|
2023
Q4 | $437K | Sell |
823
-219
| -21% | -$116K | 0.27% | 86 |
|
|
2023
Q3 | $527K | Buy |
1,042
+40
| +4% | +$20.2K | 0.36% | 60 |
|
|
2023
Q2 | $523K | Sell |
1,002
-43
| -4% | -$22.4K | 0.38% | 59 |
|
|
2023
Q1 | $602K | Sell |
1,045
-2
| -0.2% | -$1.15K | 0.47% | 51 |
|
|
2022
Q4 | $577K | Buy |
1,047
+4
| +0.4% | +$2.2K | 0.49% | 55 |
|
|
2022
Q3 | $529K | Buy |
1,043
+56
| +6% | +$28.4K | 0.5% | 51 |
|
|
2022
Q2 | $536K | Buy |
987
+17
| +2% | +$9.23K | 0.49% | 49 |
|
|
2022
Q1 | $572K | Buy |
970
+93
| +11% | +$54.8K | 0.3% | 50 |
|
|
2021
Q4 | $585K | Buy |
+877
| New | +$585K | 0.29% | 56 |
|